Home Tools
Log in
Cart

cholecystokinin

Cholecystokinin is a peptide hormone of the gastrointestinal system responsible for stimulating the digestion of fat and protein.
Cat No. product name
T4579 Pentagastrin pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally, which can cause the secretion and synthesis of salivary proteins.
TP2030L1 Gastrin I (human) acetate Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
T14932 Ceruletide Ceruletide is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic effect on the...
T9343 N-Cbz-DL-tryptophan N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.
T2312 Loxiglumide Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.
T11868 Lorglumide sodium salt Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
T1052 Proglumide Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secret...
TQ0062 Nastorazepide Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
TP1931L1 [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin...
T6735 XL413 hydrochloride XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 b...
T6206 PHA-767491 PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
T3352 XL413 XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the a...
T14932L Ceruletide Ammonium acetate Ceruletide Ammonium acetate is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bo...
T15759 Lintitript Lintitript is an orally active, competitive, and non-peptide cholecystokinin (CCK1) receptor antagonist (EC50: 6 nM; Ki: 0.2 nM). Lintitript shows > 33-fold sel...
Pentagastrin
T4579
pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally, which can cause the secretion and synthesis of salivary proteins.
Gastrin I (human) acetate
TP2030L1
Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
Ceruletide
T14932
Ceruletide is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic effect on the...
N-Cbz-DL-tryptophan
T9343
N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.
Loxiglumide
T2312
Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.
Lorglumide sodium salt
T11868
Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
Proglumide
T1052
Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secret...
Nastorazepide
TQ0062
Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate
TP1931L1
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin...
XL413 hydrochloride
T6735
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 b...
PHA-767491
T6206
PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
XL413
T3352
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the a...
Ceruletide Ammonium acetate
T14932L
Ceruletide Ammonium acetate is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bo...
Lintitript
T15759
Lintitript is an orally active, competitive, and non-peptide cholecystokinin (CCK1) receptor antagonist (EC50: 6 nM; Ki: 0.2 nM). Lintitript shows > 33-fold sel...